These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 38423750)
1. Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders. Parent HH; Niswender CM Mol Pharmacol; 2024 Apr; 105(5):348-358. PubMed ID: 38423750 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic Song JM; Kang M; Park DH; Park S; Lee S; Suh YH J Neurosci; 2021 Mar; 41(11):2344-2359. PubMed ID: 33500274 [TBL] [Abstract][Full Text] [Related]
3. Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus. Klar R; Walker AG; Ghose D; Grueter BA; Engers DW; Hopkins CR; Lindsley CW; Xiang Z; Conn PJ; Niswender CM J Neurosci; 2015 May; 35(19):7600-15. PubMed ID: 25972184 [TBL] [Abstract][Full Text] [Related]
12. Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. Bushell TJ; Sansig G; Collett VJ; van der Putten H; Collingridge GL ScientificWorldJournal; 2002 Mar; 2():730-7. PubMed ID: 12805997 [TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence. Li X; Xi ZX; Markou A Neuropharmacology; 2013 Mar; 66():12-23. PubMed ID: 22546614 [TBL] [Abstract][Full Text] [Related]
14. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice. Dobi A; Sartori SB; Busti D; Van der Putten H; Singewald N; Shigemoto R; Ferraguti F Neuropharmacology; 2013 Mar; 66():274-89. PubMed ID: 22643400 [TBL] [Abstract][Full Text] [Related]
15. Computationally Guided Identification of Allosteric Agonists of the Metabotropic Glutamate 7 Receptor. Cid JM; Lavreysen H; Tresadern G; Pérez-Benito L; Tovar F; Fontana A; Trabanco AA ACS Chem Neurosci; 2019 Mar; 10(3):1043-1054. PubMed ID: 30216043 [TBL] [Abstract][Full Text] [Related]
16. Differential Activity of Orthosteric Agonists and Allosteric Modulators at Metabotropic Glutamate Receptor 7. Lei X; Hofmann CS; Rodriguez AL; Niswender CM Mol Pharmacol; 2023 Jul; 104(1):17-27. PubMed ID: 37105671 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic profiling of mGlu Fisher NM; Gould RW; Gogliotti RG; McDonald AJ; Badivuku H; Chennareddy S; Buch AB; Moore AM; Jenkins MT; Robb WH; Lindsley CW; Jones CK; Conn PJ; Niswender CM Genes Brain Behav; 2020 Sep; 19(7):e12654. PubMed ID: 32248644 [TBL] [Abstract][Full Text] [Related]
18. International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors. Gregory KJ; Goudet C Pharmacol Rev; 2021 Jan; 73(1):521-569. PubMed ID: 33361406 [TBL] [Abstract][Full Text] [Related]
19. GRM7 gene mutations and consequences for neurodevelopment. Freitas GA; Niswender CM Pharmacol Biochem Behav; 2023 Apr; 225():173546. PubMed ID: 37003303 [TBL] [Abstract][Full Text] [Related]